Published October 2, 1984 | Version v1
Patent

Diagnostic radiopharmaceuticals for localization in target tissues exhibiting a regional PH shift relative to surrounding tissues

Description

A radiopharmaceutical chemical compound comprising a radioactive isotope, other than an isotope of iodine, in chemical combination with at least one amine group. The compound has a lipophilicity sufficiently high at a pH of 7.6 to permit passage of the compound from the blood of a mammal into a target organ or tissue and sufficiently low at a pH of 6.6 to prevent rapid return of the compound from the target organ or tissue to the blood. The compound has a percent protein binding of less than ninety percent. A method for selectively depositing a radiopharmaceutical compound in at least one target tissue or organ of a mammal, which tissue or organ has a significantly different intracellular pH than the blood of the mammal, by introducing the compound of the invention into the bloodstream of the mammal

Availability note (English)

U.S. Commissioner of Patents, Washington, D.C. 20231, USA, $.50.

Additional details

Publishing Information

Imprint Pagination
v p.
IPC:
Int. Cl. A61K 43/00; A61K 49/00.
IPC
Int. Cl. A61K 43/00; A61K 49/00.
Patent number
US patent document 4,474,746/A/

INIS

Country of Publication
United States
Country of Input or Organization
United States
INIS RN
16071484
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Resource subtype / Literary indicator
Non-conventional Literature
Descriptors DEI
AMINES; BIOLOGICAL LOCALIZATION; BLOOD; DIAGNOSIS; INTAKE; MAMMALS; NUCLEAR MEDICINE; ORGANS; PH VALUE; PROTEINS; RADIOISOTOPES; RADIOPHARMACEUTICALS; TISSUES
Descriptors DEC
ANIMALS; BIOLOGICAL MATERIALS; BODY; BODY FLUIDS; DRUGS; ISOTOPES; LABELLED COMPOUNDS; MATERIALS; MEDICINE; ORGANIC COMPOUNDS; RADIOACTIVE MATERIALS; VERTEBRATES

Optional Information

Notes
PAT-APPL-398951.